A Shot to Save the World
The Inside Story of the Life-or-Death Race for a COVID-19 Vaccine
Impossibile aggiungere al carrello
Puoi avere soltanto 50 titoli nel carrello per il checkout.
Riprova più tardi
Riprova più tardi
Rimozione dalla Lista desideri non riuscita.
Riprova più tardi
Non è stato possibile aggiungere il titolo alla Libreria
Per favore riprova
Non è stato possibile seguire il Podcast
Per favore riprova
Esecuzione del comando Non seguire più non riuscita
13,26 € per i primi 30 giorni
Offerta a tempo limitato
Attiva il tuo abbonamento Audible a 0,99 €/mese per 3 mesi per ottenere questo titolo a un prezzo esclusivo riservato agli iscritti.
Offerta valida fino alle 23.59 del 29 gennaio 2026.
Dopo 30 giorni (60 per i membri Prime), 9,99 €/mese. Puoi cancellare ogni mese
Risparmio di più del 90% nei primi 3 mesi.
Ascolto illimitato della nostra selezione in continua crescita di migliaia di audiolibri, podcast e Audible Original.
Nessun impegno. Puoi cancellare ogni mese.
Disponibile su ogni dispositivo, anche senza connessione.
Dopo esserti registrato per un abbonamento, puoi acquistare questo e tutti gli altri audiolibri nel nostro catalogo esteso, ad un prezzo scontato del 30%
Ottieni accesso illimitato a una raccolta di oltre migliaia di audiolibri e podcast originali.
Nessun impegno. Cancella in qualsiasi momento e conserva tutti i titoli acquistati.
A Shot to Save the World
Letto da:
Jack Armstrong
Acquista ora a 18,95 €
-
Letto da:
-
Jack Armstrong
A proposito di questo titolo
Longlisted for the FT/McKinsey Business Book of the Year Award
The authoritative account of the race to produce the vaccines that are saving us all, from the #1 New York Times bestselling author of The Man Who Solved the Market
Few were ready when a mysterious respiratory illness emerged in Wuhan, China in January 2020. Politicians, government officials, business leaders, and public-health professionals were unprepared for the most devastating pandemic in a century. Many of the world’s biggest drug and vaccine makers were slow to react or couldn’t muster an effective response.
It was up to a small group of unlikely and untested scientists and executives to save civilization. A French businessman dismissed by many as a fabulist. A Turkish immigrant with little virus experience. A quirky Midwesterner obsessed with insect cells. A Boston scientist employing questionable techniques. A British scientist despised by his peers. Far from the limelight, each had spent years developing innovative vaccine approaches. Their work was met with skepticism and scorn. By 2020, these individuals had little proof of progress. Yet they and their colleagues wanted to be the ones to stop the virus holding the world hostage. They scrambled to turn their life’s work into life-saving vaccines in a matter of months, each gunning to make the big breakthrough—and to beat each other for the glory that a vaccine guaranteed.
A #1 New York Times bestselling author and award-winning Wall Street Journal investigative journalist lauded for his “bravura storytelling” (Gary Shteyngart) and “first-rate” reporting (The New York Times), Zuckerman takes us inside the top-secret laboratories, corporate clashes, and high-stakes government negotiations that led to effective shots. Deeply reported and endlessly gripping, this is a dazzling, blow-by-blow chronicle of the most consequential scientific breakthrough of our time. It’s a story of courage, genius, and heroism. It’s also a tale of heated rivalries, unbridled ambitions, crippling insecurities, and unexpected drama. A Shot to Save the World is the story of how science saved the world.
Recensioni della critica
"One of the most exciting dramas in medical history... A Shot to Save the World is a thrilling account based on great reporting and access to all of the teams. An inspiring and informative page-turner.”
--Walter Isaacson, author of #1 New York Times bestseller, The Code Breaker
"Captivating account...gripping...tough to put down."
--Publishers Weekly (starred review)
“An intensely researched, rewarding account of an impressive medical triumph.”
--Kirkus Reviews
"A page-turning drama...Brings you inside the room of the largest drug makers to give readers a birds-eye view of the big decisions and behind-the-scenes machinations that span from Washington to China."
--Andrew Ross Sorkin, columnist, The New York Times, co-anchor of CNBC's Squawk Box
"Zuckerman answers a question still circulating among both vaccine fans and skeptics: How could scientists develop the Covid-19 vaccines so quickly? The vaccine-science book for a vaccine skeptic."
--The New York Times
"A propulsive narrative...the single best book I've read on the real world of scientific entrepreneurship…Highly recommended."
--Paul Kedrosky, Investor and partner at SK Venture
"Cinematic."
--Brian Williams, MSNBC
"An assured account of the research, the ideas and the personalities. Like many great scientific tales, the story features serendipity, failures, tenacity, frustration and temper tantrums."
--Nature
"A Must Read"
--Town & Country
“A superb scientific drama of failure, determination and triumph”
--The Economist, Best Books of 2021
Financial Times, Best Books of 2021, Business
--Walter Isaacson, author of #1 New York Times bestseller, The Code Breaker
"Captivating account...gripping...tough to put down."
--Publishers Weekly (starred review)
“An intensely researched, rewarding account of an impressive medical triumph.”
--Kirkus Reviews
"A page-turning drama...Brings you inside the room of the largest drug makers to give readers a birds-eye view of the big decisions and behind-the-scenes machinations that span from Washington to China."
--Andrew Ross Sorkin, columnist, The New York Times, co-anchor of CNBC's Squawk Box
"Zuckerman answers a question still circulating among both vaccine fans and skeptics: How could scientists develop the Covid-19 vaccines so quickly? The vaccine-science book for a vaccine skeptic."
--The New York Times
"A propulsive narrative...the single best book I've read on the real world of scientific entrepreneurship…Highly recommended."
--Paul Kedrosky, Investor and partner at SK Venture
"Cinematic."
--Brian Williams, MSNBC
"An assured account of the research, the ideas and the personalities. Like many great scientific tales, the story features serendipity, failures, tenacity, frustration and temper tantrums."
--Nature
"A Must Read"
--Town & Country
“A superb scientific drama of failure, determination and triumph”
--The Economist, Best Books of 2021
Financial Times, Best Books of 2021, Business
Ancora nessuna recensione